Literature DB >> 8892947

High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes.

C M Posavad1, D M Koelle, L Corey.   

Abstract

Herpes simplex virus (HSV)-specific CD8+ cytotoxic T lymphocytes (CTL) have rarely been detected in humans, presumably because of virus-induced mechanisms that downregulate major histocompatibility complex class I expression. We have developed a method that has allowed us to consistently demonstrate HSV-specific CD8+ precursor CTL (pCTL) from HSV type 1- and 2-seropositive persons. Major histocompatibility complex-restricted HSV-specific CD8+ pCTL were found in 10 consecutively tested HSV type 1- and 2-seropositive subjects at frequencies ranging from 1 in 21,000 to 1 in 300 (median, 1 in 6,000) versus a pCTL frequency of 1 in 100,000 in HSV-seronegative donors. These results suggest that CD8+ CTL are important effector cells in resolving HSV lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892947      PMCID: PMC190896     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

Authors:  I A York; C Roop; D W Andrews; S R Riddell; F L Graham; D C Johnson
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

2.  Herpes simplex virus infection of human T-cell subpopulations.

Authors:  S M Hammer; W P Carney; V R Iacoviello; B R Lowe; M S Hirsch
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

3.  Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.

Authors:  R W Braun; H K Teute; H Kirchner; K Munk
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

4.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 5.  Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.

Authors:  A J Nahmias; F K Lee; S Beckman-Nahmias
Journal:  Scand J Infect Dis Suppl       Date:  1990

6.  Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.

Authors:  D M Koelle; H Abbo; A Peck; K Ziegweid; L Corey
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

7.  Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

Authors:  D M Koelle; M A Tigges; R L Burke; F W Symington; S R Riddell; H Abbo; L Corey
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.

Authors:  Z Mikloska; A M Kesson; M E Penfold; A L Cunningham
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

9.  Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.

Authors:  D M Koelle; L Corey; R L Burke; R J Eisenberg; G H Cohen; R Pichyangkura; S J Triezenberg
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.

Authors:  M A Tigges; D Koelle; K Hartog; R E Sekulovich; L Corey; R L Burke
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  31 in total

Review 1.  Immunomodulation by thalidomide and thalidomide analogues.

Authors:  L G Corral; G Kaplan
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.

Authors:  David M Koelle; Zhi Liu; Christopher L McClurkan; Randal C Cevallos; Jeffrey Vieira; Nancy A Hosken; Clement A Meseda; Devon C Snow; Anna Wald; Lawrence Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

3.  Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.

Authors:  Malgorzata Gierynska; Uday Kumaraguru; Seong-Kug Eo; Sujin Lee; Arthur Krieg; Barry T Rouse
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.

Authors:  Sabine Vollstedt; Susi Arnold; Cornelia Schwerdel; Marco Franchini; Gottfried Alber; James P Di Santo; Mathias Ackermann; Mark Suter
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.

Authors:  Sita Awasthi; Gregory G Mahairas; Carolyn E Shaw; Meei-Li Huang; David M Koelle; Christine Posavad; Lawrence Corey; Harvey M Friedman
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

6.  Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2.

Authors:  Christine M Posavad; Amalia S Magaret; Lin Zhao; Dawn E Mueller; Anna Wald; Lawrence Corey
Journal:  Vaccine       Date:  2011-07-27       Impact factor: 3.641

7.  Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

Authors:  D M Koelle; C M Posavad; G R Barnum; M L Johnson; J M Frank; L Corey
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Authors:  K Olson; P Macias; S Hutton; W A Ernst; G Fujii; J P Adler-Moore
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

10.  Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

Authors:  Lbachir BenMohamed; Georges Bertrand; Cory D McNamara; Helene Gras-Masse; Juergen Hammer; Steven L Wechsler; Anthony B Nesburn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.